相关实验视频
Updated: Jan 15, 2026

15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
23.7K
随着COPD的严重程度,菌体的多样性在呼吸道微生物群中下降
Ryan A Cook1, Alise J Ponsero1, Andrea Telatin1
1Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Cell reports
|October 9, 2025
概括
菌体,感染细菌的病毒,在慢性阻塞性肺病 (COPD) 中发生变化. 它们与细菌的破坏关系可能会导致疾病的严重程度和恶化.
科学领域:
- 微生物学 微生物学
- 病毒学 病毒学
- 肺部医学 肺部医学
背景情况:
- 慢性阻塞性肺病 (COPD) 与呼吸道微生物失衡有关.
- 菌体的作用,感染细菌的病毒,在COPD的发病过程中在很大程度上是未知的.
研究的目的:
- 为了鉴定COPD患者肺部DNA病毒的特征.
- 研究菌体多样性,丰富性和COPD严重性之间的关系.
- 在COPD恶化的背景下探索细菌-细菌相互作用.
主要方法:
- 重新分析了来自99名COPD患者和36名健康对照的135个甲基因组.
- 病毒操作分类单位 (vOTU) 的识别和量化.
- 病毒和细菌多样性与疾病严重程度和恶化频率的相关性分析.
主要成果:
- 随着COPD严重程度的增加,病毒的多样性下降.
- 患有频繁恶化的患者显示病毒-细菌多样性相关性被破坏.
- 感染无氧口腔细菌 (例如,Porphyromonas) 的菌体在COPD中显著减少.
- 检测到编码毒性因子的菌体,并与增加的细菌丰度有关.
结论:
- 改变的细菌生态是COPD的一个新特征.
- 不同的菌-细菌相互作用重塑COPD中的肺微生物生态系统.
- 这些发现表明,在COPD中,有潜在的针对微生物组的治疗干预措施.
相关概念视频
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Pneumonia II: Pathophysiology
2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
726
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
726

